Close

Jefferies Sees Haemonetics (HAE) as Oversold Ahead of Earnings, PT Lowered $105

May 12, 2021 8:10 AM EDT Send to a Friend
Jefferies analyst Anthony Petrone lowered the price target on Haemonetics (NYSE: HAE) to $105.00 (from $185.00) ahead of the F4Q ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login